Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

John Campbell (NPI 1255598041)

Field	Value
Entity Type	Individual
Organization	John Campbell
Address	3375 Sw Terwilliger Blvd
City	Portland
State	OR
ZIP	97239
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	May 20, 2008

Payer Source	Total Paid
Medicare	$885.9K
Medicaid	$0

Key Findings

This provider’s Medicare activity is heavily weighted toward intravitreal injections and retina-specific diagnostics: J0178 (aflibercept injections), J2777 (faricimab injections), 67028 (intravitreal injection procedure), and 92134 (retinal imaging) together define the clinical mix and day-to-day services reported. The presence of high-volume drug administration codes alongside retina imaging (92134) and procedure code 67028 is consistent with a retina specialist practice focused on office-based intravitreal therapy and monitoring rather than surgical retina or broad ophthalmology services.

Revenue concentration is pronounced: the precomputed top three Medicare codes account for 88.2% of the provider’s total Medicare revenue, with J0178 alone representing $632.2K (71.4% of total Medicare revenue). That level of concentration around a single anti-VEGF product indicates that overall Medicare income is highly dependent on continued use and reimbursement of that drug and its administration.

The provider’s payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $885.9K and Medicaid shows none (no Medicaid billing on file). This near-exclusive Medicare reliance may simplify billing patterns but concentrates reimbursement risk and limits visibility into state Medicaid volumes or contract negotiations.

On national competitive standing for the primary drug, J0178 is responsible for 938 claims and $632.2K in revenue and the provider ranks #1348 of 3204 nationally (58th percentile), which the source labels as typical or unremarkable volume. In plain terms, the provider is a solid but not dominant national participant for aflibercept administration based on rank and claim counts.

Use of J2777 and 67028 shows mixed positioning: J2777 appears in 2.9K claims and $85.3K revenue but ranks #1854 of 2039 nationally (9th percentile), indicating comparatively low standing among peers for that code despite high claim counts reported here; 67028 has 636 claims, $64.2K revenue and ranks #1907 of 4255 (55th percentile), placing it near the middle of national peers. The low percentile for J2777 alongside modest rank positions for 67028 suggests selective use of newer therapies and routine intravitreal procedural volumes rather than leadership in those categories.

Diagnostic and evaluation services complement the injection workstream: 92134 (908 claims, $28.1K) ranks #2319 of 26868 (91st percentile), showing strong relative imaging volume, while office evaluation codes 99214 (362 claims, $34.8K, 83rd percentile) and 99213 (235 claims, $15.3K, 82nd percentile) are also above typical peers. These higher percentiles for imaging and E/M imply robust monitoring and follow-up activity, consistent with ongoing anti-VEGF management protocols.

Compounded drugs (J7999) account for $20.7K (2.3% of Medicare revenue) with 284 claims and a national rank of #349 of 1333 (74th percentile), indicating a higher-than-typical use of compounded therapies relative to many peers. This could reflect adjunctive or specialty compounded medications used in retinal care or clinic-specific compounding practices.

The provider has an established NPI history, enumerated 2008-05-20 (~18 years ago), which suggests operational stability and a long-standing presence in the market. The tenure combined with the concentrated anti-VEGF revenue profile paints a picture of an experienced retina specialist whose Medicare business is stable but dependent on a narrow set of services and drugs.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

9 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	940	$670	$632.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	2,940	$30	$85.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	640	$100	$64.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	360	$100	$34.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	910	$30	$28.1K
J7999	Compounded drug, not otherwise classified	280	$70	$20.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	240	$70	$15.3K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	40	$90	$3.3K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	20	$120	$1.9K

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

John Campbell — 0 of 9 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

9 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	27	60	840	$680	$623.7K
J2777	34	30	10,050	$30	$527.6K
67028	35	70	580	$90	$72.3K
J7999	26	50	270	$70	$23.4K
92014	327	440	110	$80	$16K
99214	497	6,070	80	$70	$10.3K
92134	39	390	80	$30	$8.1K
99213	548	5,480	60	$50	$5.7K
99204	2,069	2,750	30	$110	$4.4K

Related Providers

Other providers that share a Tax Identification Number (TIN) with John Campbell, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
University Professional Services	OR	General Practice Physician	$0	$55.6M
Legacy Clinics LLC	OR	Clinic/Center	$35.6K	$48.7M
University Professional Services	OR	Pharmacy	$0	$8.1M
Rene Choi	OR	Ophthalmology Physician	$2.2M	$0
Dong-wouk Park	WA	Retina Specialist (Ophthalmology) Physician	$1.9M	$0
Scott Mcclintic	OR	Ophthalmology Physician	$1.7M	$0
Ngoc-lam Nguyen	FL	Orthopaedic Surgery of the Spine Physician	$1.3M	$0
Steven Bailey	OR	Retina Specialist (Ophthalmology) Physician	$1M	$0
University Professional Services	OR	General Practice Physician	$0	$988.2K
Andrew Henning	OR	Family Nurse Practitioner	$675.9K	$0

Nearby Providers

Other providers in the same ZIP code as John Campbell, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Oregon Health & Science University	OR	General Acute Care Hospital	$0	$70.6M
Oregon Health & Science University	OR	Clinic/Center	$0	$52.1M
Shriners Hospitals For Children	OR	Children's Hospital	$0	$3.9M
Portland Dbt Institute, Inc.	OR	Cognitive & Behavioral Psychologist	$0	$3.7M
Housecall Providers, PC	OR	Family Medicine Physician	$0	$2M
Pediatric Orthotic And Prosthetic Services - Northwest, LLC	OR	Prosthetic/Orthotic Supplier	$0	$1.2M
Housecall Providers Services, LLC	OR	Community Based Hospice Care Agency	$0	$953.5K
Mind Solutions LLC	OR	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$952.2K
Merina Thomas	OR	Retina Specialist (Ophthalmology) Physician	$640.5K	$0
Nieraj Jain	OR	Ophthalmology Physician	$387.4K	$0

John Campbell — Billing Profile & Reimbursement Data

Sign up for John Campbell — Billing Profile & Reimbursement Data policy alerts

John Campbell — Billing Profile & Reimbursement Data

Sign up for John Campbell — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References